MedPath

A randomized controlled trial for the effectiveness of self-management education using structured self-monitoring of blood glucose in noninsulin-treated type 2 diabetes patients

Not Applicable
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000016016
Lead Sponsor
Faculty of Health & Social Services, Kanagawa University of Human Services
Brief Summary

This was a randomized controlled study to assess the effectiveness of structured self-monitoring of blood glucose testing among noninsulin-treated type 2 diabetes patients. Patients were recruited and randomized to a control group (CG) with usual care or a structured testing group (STG) at least every other month use of structured self-monitoring of blood glucose (SMBG). STG patients were trained to use a paper tool to collect 7-point glucose profiles over 3 consecutive days. The primary end point was HbA1c level measured at 6 months. The 6-month median HbA1c (IQR) of STG group was 7.2% and that of CG group was 7.6%; there was no statistically significant deference between them. Only the STG group showed significant reductions of median HbA1c from 7.5% to 7.2%.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

1.type 1 diabetes 2.currently treated by dementia, psychosis, recent emotional trauma 3.used steroids more than 14 days within the last 3 months 4.treated with chemotherapy or radiation therapy 5.pregnant or breast feeding 6.had severe depression or other severe psychological conditions

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in HbA1c (after 6 months and 12 months from starting SMBG use)
Secondary Outcome Measures
NameTimeMethod
1.Self-efficacy for health behavior 2.health and life habit 3.health literacy (after 6 months and 12 months from starting SMBG use)
© Copyright 2025. All Rights Reserved by MedPath